Downregulation of EMX2 is associated with clinical outcomes in lung adenocarcinoma patients.
Okamoto J, Kratz JR, Hirata T, Mikami I, Raz D, Segal M, Chen Z, Zhou HM, Pham P, Li H, Yagui-Beltran A, Ray MR, Koizumi K, Shimizu K, Jablons D, He B.
Okamoto J, et al.
Clin Lung Cancer. 2011 Jul;12(4):237-44. doi: 10.1016/j.cllc.2011.03.025. Epub 2011 Apr 24.
Clin Lung Cancer. 2011.
PMID: 21726823
Free PMC article.